QIAGEN is a provider of sample preparation and molecular diagnostic and research assay technologies used in life sciences, clinical, and applied testing markets.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 42 | New buy | 259 | $11,334 | 0.0% |
| Bridgewater | 55 | New buy | 69,680 | $3,049,197 | 0.0% |
| Louis Bacon / Moore | 52 | New buy | 32,297 | $1,413,317 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Added +979% | 455,371 | $19,927,035 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -70% | 482,956 | $21,134,155 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.